Three neuroleptanalgesia schedules for laparoscopic sterilization by electrocoagulation.
Women undergoing interval laparoscopic electrocoagulation sterilization were randomly assigned to one of three neuroleptanalgesia regimens. The 299 women received either morphine (10 mg)/droperidol (2.5 mg)/atropine (0.3 mg) or pethidine (100 mg)/droperidol (2.5 mg)/atropine (0.3 mg) or pethidine (100 mg)/droperidol (2.5 mg). A significantly higher proportion of anesthesia complications were recorded in the morphine group. The amount of pain experienced by the women was similar in the three groups, as were the rates of early follow-up complications and complaints. The neuroleptanalgesia regimen containing pethidine/droperidol/atropine appears to be the safest and most effective of the three considered here.
D000328:Adult; D001285:Atropine; D004329:Droperidol; D004338:Drug Combinations; D004564:Electrocoagulation / Q000379:methods; D005260:Female; D006801:Humans; D010535:Laparoscopy; D008614:Meperidine; D009020:Morphine; D009458:Neuroleptanalgesia / Q000009:adverse effects; D011183:Postoperative Complications; D012959:Socioeconomic Factors; D013246:Sterilization, Tubal / Q000379:methods*
D004338:Drug Combinations; D009020:Morphine; D001285:Atropine; D008614:Meperidine; D004329:Droperidol